WEE1 and cancer: These kinases have been recognized as valid targets for anti-cancer therapeutics, and up until now, the US FDA has approved more than 73 small molecules regarding protein kinase inhibitors; most are multi-targeted tyrosine kinase inhibitors (MT-TKIs) [14,15,16,17].